As of October 24, 2026, 08:51 PM ET, Polymarket traders price December 31, 2026 at 49.0% in FDA moves BPC-157 to Category 1 by…? — $4.8K traded so far.
The leading outcome, December 31, 2026, is priced at 49.0%.
Price changes for the leading market — past week: -4.5 pts; past month: -5.5 pts.
Since June 23, 2026, December 31, 2026 has traded between 28.5% and 75.5%. It opened at 49.5% and last traded at 49.0%.
| Day | Close |
|---|---|
| Oct 16, 2026 | 51.0% |
| Oct 17, 2026 | 51.5% |
| Oct 18, 2026 | 50.5% |
| Oct 19, 2026 | 52.5% |
| Oct 20, 2026 | 48.5% |
| Oct 22, 2026 | 51.0% |
| Oct 23, 2026 | 49.0% |
December 31, 2026 is favored at 49.0%.
| Outcome | Price | Implied probability | 24h change | Volume | Volume share |
|---|---|---|---|---|---|
| December 31, 2026 | 49¢ | 49.0% | — | $2.8K | 58.2% |
See the full live book for this market on Polymarket
The leading market's spread is 60¢ (bid 19¢ / ask 79¢) — a tighter spread means cheaper round-trip trading.
$4.8K has been traded on this event in total, $5 of it in the last 24 hours, across 1 market.
This market is scheduled to end December 31, 2026, 11:59 PM ET.
This market will resolve to “Yes” if the Food and Drug Administration (FDA) announces that it has reclassified or will reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by the listed date, 11:59 PM ET. Otherwise, this market will resolve to “No”. A qualifying announcement must be official and public. Any rumored or private statements of intention will not qualify. Any announcement that the drug has been reclassified to Category 1 will qualify. Any announcement within this market’s timeframe of future intention to reclassify to Category 1 will qualify regardless of whether the reclassification has happened by the listed date. A qualifying reclassification must be to Category 1 of the Bulk Drug Substances List or an equivalent classification that allows interim compounding of the drug. Removal from a different category will not qualify. The resolution source for this market will be official statements from the FDA; however, a consensus of credible reporting will also be used.
The largest current holder of the leading market holds 154 shares of Yes.
| Holder | Outcome held | Shares | Value at current price |
|---|---|---|---|
| Repentant-Graphic | Yes | 154 | $75 |
| GruBBa | No | 94 | $48 |
| Amazing-Pad | Yes | 60 | $29 |
| Joyous-Catalyst | No | 50 | $26 |
| Wise-Keyboard | Yes | 43 | $21 |
| Belated-Glue | No | 30 | $15 |
| Innocent-Facility | No | 20 | $10 |
| Wet-Event | No | 20 | $10 |
| Purple-Fruit | Yes | 16 | $8 |
| Stable-Conversation | No | 15 | $8 |
| Time | Outcome | Side | Price | Size |
|---|---|---|---|---|
| Oct 23, 10:37 PM ET | Yes | BUY | 48.0% | $2 |
| Oct 14, 09:04 PM ET | Yes | BUY | 11.0% | $1 |
| Oct 08, 08:21 PM ET | No | BUY | 53.0% | $5 |
| Sep 28, 10:31 AM ET | No | BUY | 26.0% | $6 |
| Sep 28, 02:37 AM ET | No | BUY | 50.0% | $15 |
| Sep 28, 12:04 AM ET | No | BUY | 50.0% | $10 |
| Sep 26, 07:24 PM ET | Yes | BUY | 45.0% | $14 |
| Sep 25, 03:53 AM ET | No | BUY | 78.0% | $5 |
| Sep 25, 03:53 AM ET | No | BUY | 78.0% | $5 |
| Sep 21, 12:42 PM ET | No | SELL | 10.0% | $10 |
As of October 24, 2026, 08:45 PM ET, the leading outcome is December 31, 2026 at 49.0%. See the live book on Polymarket: https://polymarket.com/event/fda-moves-bpc-157-to-category-1-by-20260622202229566?via=bro
$4.8K in total volume, with $5 traded in the last 24 hours across 1 markets.
The market is scheduled to end December 31, 2026, 11:59 PM ET.
December 31, 2026, priced at 49.0% as of October 24, 2026, 08:45 PM ET. Prices are implied probabilities backed by real-money trading.
Browse the live odds index, today's biggest movers, and Whale Watch for the largest positions.
Prices move fast. Check the live book, read the resolution rules, and size small while you learn.
Sign Up on PolymarketNew here? Start with the complete beginner guide, then run any stake through the payout calculator before you trade.